Literature DB >> 19811385

A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies.

Bo Lundbäck1, Berne Eriksson, Anne Lindberg, Linda Ekerljung, Hana Muellerova, Lars-Gunnar Larsson, Eva Rönmark.   

Abstract

Mortality and other long-term outcomes of COPD from epidemiological studies of cohorts based on the general population are still rare. In contrast, data from follow-ups of patients from hospitals and general practices are more common and demonstrate often a 5-year mortality of about 50% and even higher. The aim was to study 20-year outcomes, mainly mortality, in a COPD cohort derived from a population study. The Obstructive Lung Disease in Northern Sweden (OLIN) Study's first postal survey was performed in 1985, and 5698 subjects (86%) responded. A stratified sample of symptomatic subjects and controls was invited to clinical examinations including lung function tests in 1986, 1506 (91%) of the invited participated and 266 subjects fulfilled the GOLD criteria of COPD. All alive and possible to trace had participated at least at two follow-up examinations. Of the 266 subjects with COPD 46% were still alive after 20 years. The proportion of survived among subjects with severe and very severe COPD at entry was 19%. Death was significantly related to age, male sex, disease severity and concomitant ischemic heart disease or cardiac failure at entry. Socioeconomic status (manual workers) was significant in the univariate analysis, but failed to reach statistical significance in the multivariate model. The annual decline in FEV(1) among survivors was low to normal. Long-term follow-ups of subjects with COPD derived from population studies provide data reflecting the course of COPD in society better than follow-ups of hospital recruited patients, who represent the top of the iceberg. Surprisingly many with severe COPD were still alive after 20 years.

Entities:  

Mesh:

Year:  2009        PMID: 19811385     DOI: 10.1080/15412550903061483

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  15 in total

1.  Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments.

Authors:  Bernardino Roca; Pedro Almagro; Francisco López; Francisco J Cabrera; Lorena Montero; David Morchón; Jesús Díez; Fernando de la Iglesia; Mario Fernández; Jesús Castiella; Elena Zubillaga; Jesús Recio; Joan B Soriano
Journal:  Intern Emerg Med       Date:  2010-10-01       Impact factor: 3.397

2.  Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: the Rancho Bernardo study.

Authors:  Hwa Mu Lee; Michael A Liu; Elizabeth Barrett-Connor; Nathan D Wong
Journal:  Respir Med       Date:  2014-10-06       Impact factor: 3.415

3.  Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease.

Authors:  Soo Kyung Park; Janet L Larson
Journal:  J Clin Nurs       Date:  2014-01-27       Impact factor: 3.036

4.  Obstructive pulmonary disease in old age among individuals born preterm.

Authors:  Eva Berggren Broström; Olof Akre; Miriam Katz-Salamon; David Jaraj; Magnus Kaijser
Journal:  Eur J Epidemiol       Date:  2013-01-23       Impact factor: 8.082

5.  Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries.

Authors:  Gunnar Gudmundsson; Charlotte Suppli Ulrik; Thorarinn Gislason; Eva Lindberg; Eva Brøndum; Per Bakke; Christer Janson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-14

6.  Up-to-date on mortality in COPD - report from the OLIN COPD study.

Authors:  Anne Lindberg; Lars-Gunnar Larsson; Hana Muellerova; Eva Rönmark; Bo Lundbäck
Journal:  BMC Pulm Med       Date:  2012-01-09       Impact factor: 3.317

7.  Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.

Authors:  Robert Linder; Eva Rönmark; Jamshid Pourazar; Annelie Behndig; Anders Blomberg; Anne Lindberg
Journal:  Respir Res       Date:  2015-02-21

8.  Improving clinical reality in chronic obstructive pulmonary disease economic modelling : development and validation of a micro-simulation approach.

Authors:  Yumi Asukai; Michael Baldwin; Tiago Fonseca; Alastair Gray; Laura Mungapen; David Price
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981

Review 9.  Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis.

Authors:  A Alshabanat; Z Zafari; O Albanyan; M Dairi; J M FitzGerald
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

10.  Association between Severity of Chronic Obstructive Pulmonary Disease and Lung Function Tests.

Authors:  Hamid Reza Jamaati; Bahareh Heshmat; Ronak Tamadon; Abbas Hamidi Rad; Seyed Amir Mohajerani; Golnar Radmand; Seyed Mohammad Reza Hashemian
Journal:  Tanaffos       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.